EVOLUS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
EVOLUS, INC. (EOLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.32 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-02-25
- EVOLUS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 263.61K shares, a 83.21% decline year-over-year.
- EVOLUS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-03-31 was 822.98K shares.
- EVOLUS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 349.24K shares.
- EVOLUS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was 1.57M shares.
- EVOLUS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.32M shares, a 65.59% decline from fiscal 2018.
- EVOLUS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 3.84M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2019-12-31 | 1.32M shares 10-K · filed 2020-02-25 | |||
| 2019-06-30 | 263.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | 1.09M shares 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | 822.98K shares 10-Q · filed 2019-05-01 | |||
| 2018-12-31 | 3.84M shares 10-K · filed 2019-03-20 | |||
| 2018-09-30 | 349.24K shares 10-Q · filed 2018-11-05 | 1.92M shares derived: sum of 2 quarters · filed 2018-11-05 | ||
| 2018-06-30 | 1.57M shares 10-Q · filed 2018-11-05 | |||
| 2018-02-19 | 102.83K shares 10-Q · filed 2018-11-05 | |||
| 2018-01-06 | 1.50M shares 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |